Dongyang Tang
Impact in
-
- Cancer-related molecular mechanisms research
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer-related molecular mechanisms research 4
-
- Ubiquitin and proteasome pathways 4
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Xin Zhao (7 shared papers)Cheng Wang (6 shared papers)Zhiwei Peter Wang (2 shared papers)Xiangdong Gao (2 shared papers)Xiaofei Chen (2 shared papers)Wenbing Yao (1 shared paper)Jing Fei Zhu (1 shared paper)Li Zhang (1 shared paper)
In The Last Decade
Dongyang Tang
23 papers receiving 664 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 134
- Biomaterials 82
- Oncology 132
- Cell Biology 82
- Molecular Biology 266
Countries citing papers authored by Dongyang Tang
This map shows the geographic impact of Dongyang Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongyang Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongyang Tang more than expected).
Fields of papers citing papers by Dongyang Tang
This network shows the impact of papers produced by Dongyang Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongyang Tang. The network helps show where Dongyang Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongyang Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 158 | |
| 2 | 2013 | 96 | |
| 3 | 2018 | 65 | |
| 4 | 2018 | 52 | |
| 5 | 2018 | 45 | |
| 6 | 2023 | 36 | |
| 7 | 2019 | 34 | |
| 8 | 2019 | 26 | |
| 9 | 2020 | 26 | |
| 10 | 2017 | 25 | |
| 11 | 2019 | 24 | |
| 12 | 2019 | 19 | |
| 13 | 2012 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2019 | 12 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2025 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 2 |
About Dongyang Tang
Dongyang Tang is a scholar working on Cancer Research, Molecular Biology, Oncology, Materials Chemistry and Biomaterials, having authored 28 papers that have together received 670 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (4 papers), Luminescence Properties of Advanced Materials (3 papers), Aluminum Alloy Microstructure Properties (3 papers), Solid State Laser Technologies (2 papers), Glycosylation and Glycoproteins Research (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Microstructure and mechanical properties (2 papers). The work is most often cited by research in Cancer Research (134 citations), Biomaterials (82 citations), Oncology (132 citations), Cell Biology (82 citations) and Molecular Biology (266 citations). Dongyang Tang has collaborated with scholars based in China, Macao and Czechia. Frequent co-authors include Xin Zhao, Cheng Wang, Zhiwei Peter Wang, Xiangdong Gao, Xiaofei Chen, Wenbing Yao, Jing Fei Zhu, Li Zhang, Bin Wang and Shaoqing Chen. Their work appears in journals such as Advanced Science, Journal of Cellular Physiology, Journal of Cellular Biochemistry, Drug Resistance Updates and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.